Search results

This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance

Each year we work with NHSE and the DHSC to prioritise topics for development.

Tell us about an interventional procedure you think should be assessed by NICE.

Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018. All rights reserved....

Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings {"@context":"http://schema

Our associates help us to support high quality, safe, cost-effective prescribing and medicines optimisation.

Home Get involved Our committees...

Home Get involved Help develop quality standards...

Study NICE and LSE's Executive MSc Healthcare Decision-Making

NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,